A Study of Degarelix in Patients With Prostate Cancer

Clinical trial NCT00928434 · COMPLETED

Trial details

NCT number: NCT00928434
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2009-05-01
Primary completion: 2012-08-01
Enrollment: 409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.